Derek Miller - Apr 30, 2023 Form 4 Insider Report for AMGEN INC (AMGN)

Role: SVP, Human Resources
Signature: /s/ Derek Miller
Stock symbol: AMGN
Transactions as of: Apr 30, 2023
Transactions value $: -$11,987
Form type: 4
Date filed: 5/2/2023, 08:26 PM
Previous filing: Mar 20, 2023
Next filing: May 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	Price $	Shares After	Date	Ownership	Footnotes
transaction	AMGN	Common Stock	Tax liability	-$12 K	-50	-0.76%	$239.74	6.56 K	Apr 30, 2023	Direct	F1, F2

Explanation of Responses:

Id	Content
F1	These shares include the following Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Equity Incentive Plan:144 RSUs which vest on 5/3/2023; 269 RSUs which will vest in installments of 132 on 5/5/2023 and 137 on 5/5/2024; 263 RSUs which will vest in one installment of 129 on 4/30/2024 and one installment of 134 on 4/30/2025; 175 RSUs which will vest on 11/5/2023; and 866 RSUs which will vest in installments of 285 on 5/2/2024, 286 on 5/2/2025, and 295 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
F2	These shares include 100 DEs granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Content

These shares include the following Restricted Stock Units (RSUs) granted under the Amgen Inc. 2009 Equity Incentive Plan:144 RSUs which vest on 5/3/2023; 269 RSUs which will vest in installments of 132 on 5/5/2023 and 137 on 5/5/2024; 263 RSUs which will vest in one installment of 129 on 4/30/2024 and one installment of 134 on 4/30/2025; 175 RSUs which will vest on 11/5/2023; and 866 RSUs which will vest in installments of 285 on 5/2/2024, 286 on 5/2/2025, and 295 on 5/2/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

These shares include 100 DEs granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.